glp-1 weight loss drug news today 2025 Patients taking an experimental oral lost significant and improved heart and metabolic risk factors in a large, worldwide phase 3 clinical trial led by Weill Cornell Medicine and other New GLP-1 alternative, eloralintide, leads

Always discuss your current medications with your healthcare provider before starting Mounjaro

In a recently published landmark phase III study in patients with overweight or obesity (STEP 1), greater reductions in body weight were observed after 68 weeks of treatment with once-weekly semaglutide 2.4 mg vs

The semaglutide mixing chart provides a comprehensive reference for all common vial sizes and water volumes, and for anyone working with the 10mg format, the 10mg bacteriostatic water mixing guide covers the specific calculations needed

The combination proves popular for age-related growth hormone decline, physique enhancement, and injury recovery, though it remains contraindicated in individuals with active malignancy, uncontrolled diabetes, severe cardiovascular disease, and in athletes governed by WADA anti-doping regulations